Renadirsen

Explore a selection of our essential drug information below, or:

CREATE FREE ACCOUNT

Full Drug Profiles

Unlock enhanced features & extensive drug insights, including detailed interaction data & regulatory status. Create a free account.

SUBSCRIBERECOMMENDED FOR PHARMA

Data Packages

Explore the full scope of our drug knowledge tailored for pharmaceutical research needs in our data library. Learn more.

Identification

Generic Name

Renadirsen

DrugBank Accession Number

DB19132

Background

Renadirsen is under investigation in clinical trial NCT04433234 (Long-term, Extension Study of Ds-5141b in Patients With Duchenne Muscular Dystrophy).

Type

Small Molecule

Groups

Investigational

Structure

Download

MOLSDFPDBSMILESInChI

Similar Structures

Structure for Renadirsen (DB19132)

×

Close

Weight

Average: 6552.43
Monoisotopic: 6547.811151403

Chemical Formula

C₂₀₈H₂₇₅N₆₃O₁₁₀P₁₈S₁₈

Synonyms

• Renapersen

External IDs

• DS-5141b

Poor quality drug data slowing you down?

Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.

Download eBook

Poor quality drug data slowing you down?

Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

Not Available

Categories

Drug Categories

Not Available

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

4RW6WRD7SW

CAS number

1782108-31-9

InChI Key

DYDGGTWPZKPVKH-UHFFFAOYSA-N

InChI

InChI=1S/C208H275N63O110P18S18/c1-82-45-256(189(282)238-144(82)210)174-124-134(199(63-273,354-174)21-34-318-124)372-386(296,404)332-61-98-114(122(316-17)172(352-98)270-80-234-106-159(270)247-185(222)250-164(106)278)370-394(304,412)340-67-204-26-39-327-133(181(358-204)263-52-89(8)151(217)245-196(263)289)143(204)381-399(309,417)345-72-208-30-43-323-129(183(363-208)265-54-91(10)162(276)253-198(265)291)139(208)377-389(299,407)335-60-97-112(121(315-16)171(351-97)269-79-233-105-158(269)246-184(221)249-163(105)277)366-384(294,402)329-55-92-108(116(310-11)166(346-92)254-31-19-100(209)236-187(254)280)367-391(301,409)338-65-201-23-36-325-131(179(355-201)261-50-87(6)149(215)243-194(261)287)141(201)379-397(307,415)343-70-206-28-41-321-127(177(360-206)259-48-85(4)147(213)241-192(259)285)137(206)375-388(298,406)334-59-96-111(119(313-14)169(350-96)267-77-231-103-153(219)225-74-228-156(103)267)365-385(295,403)331-57-94-113(120(314-15)170(348-94)268-78-232-104-154(220)226-75-229-157(104)268)369-393(303,411)337-64-200-22-35-322-128(182(362-200)264-53-90(9)161(275)252-197(264)290)138(200)376-390(300,408)336-62-99-115(123(317-18)173(353-99)271-81-235-107-160(271)248-186(223)251-165(107)279)371-395(305,413)341-68-203-25-38-326-132(180(357-203)262-51-88(7)150(216)244-195(262)288)142(203)380-398(308,416)344-71-207-29-42-320-126(176(361-207)258-47-84(3)146(212)240-191(258)284)136(207)374-387(297,405)333-58-95-110(118(312-13)168(349-95)266-76-230-102-152(218)224-73-227-155(102)266)364-383(293,401)330-56-93-109(117(311-12)167(347-93)255-32-20-101(274)237-188(255)281)368-392(302,410)339-66-202-24-37-324-130(178(356-202)260-49-86(5)148(214)242-193(260)286)140(202)378-396(306,414)342-69-205-27-40-319-125(135(205)373-382(292,400)328-44-33-272)175(359-205)257-46-83(2)145(211)239-190(257)283/h19-20,31-32,45-54,73-81,92-99,108-143,166-183,272-273H,21-30,33-44,55-72H2,1-18H3,(H,292,400)(H,293,401)(H,294,402)(H,295,403)(H,296,404)(H,297,405)(H,298,406)(H,299,407)(H,300,408)(H,301,409)(H,302,410)(H,303,411)(H,304,412)(H,305,413)(H,306,414)(H,307,415)(H,308,416)(H,309,417)(H2,209,236,280)(H2,210,238,282)(H2,211,239,283)(H2,212,240,284)(H2,213,241,285)(H2,214,242,286)(H2,215,243,287)(H2,216,244,288)(H2,217,245,289)(H2,218,224,227)(H2,219,225,228)(H2,220,226,229)(H,237,274,281)(H,252,275,290)(H,253,276,291)(H3,221,246,249,277)(H3,222,247,250,278)(H3,223,248,251,279)/t92-,93-,94-,95-,96-,97-,98-,99-,108-,109+,110+,111-,112-,113+,114-,115+,116+,117-,118-,119-,120-,121+,122+,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134+,135-,136-,137+,138-,139+,140-,141+,142-,143+,166-,167-,168-,169+,170-,171-,172-,173-,174+,175-,176-,177+,178-,179+,180-,181+,182-,183+,199-,200+,201-,202+,203+,204-,205+,206-,207+,208-,382?,383?,384?,385?,386?,387?,388?,389?,390?,391?,392?,393?,394?,395?,396?,397?,398?,399?/m1/s1

IUPAC Name

SMILES

CO[C@@H]1[C@H](OP(S)(=O)OC[C@H]2O[C@H]([C@H](OC)[C@@H]2OP(S)(=O)OC[C@@]23CCO[C@@H]([C@@H](O2)N2C=C(C)C(=O)NC2=O)[C@@H]3OP(S)(=O)OC[C@H]2O[C@H]([C@H](OC)[C@@H]2OP(S)(=O)OC[C@@]23CCO[C@@H]([C@@H](O2)N2C=C(C)C(N)=NC2=O)[C@@H]3OP(S)(=O)OC[C@@]23CCO[C@@H]([C@@H](O2)N2C=C(C)C(N)=NC2=O)[C@@H]3OP(S)(=O)OC[C@H]2O[C@H]([C@H](OC)[C@@H]2OP(S)(=O)OC[C@H]2O[C@H]([C@H](OC)[C@@H]2OP(S)(=O)OC[C@@]23CCO[C@@H]([C@@H](O2)N2C=C(C)C(N)=NC2=O)[C@@H]3OP(S)(=O)OC[C@@]23CCO[C@@H]([C@@H](O2)N2C=C(C)C(N)=NC2=O)[C@@H]3OP(S)(=O)OCCO)N2C=CC(=O)NC2=O)N2C=NC3=C(N)N=CN=C23)N2C=NC3=C2N=C(N)NC3=O)N2C=NC3=C(N)N=CN=C23)[C@@H](COP(S)(=O)O[C@H]2[C@H]3OCC[C@]2(COP(S)(=O)O[C@H]2[C@H]4OCC[C@]2(COP(S)(=O)O[C@@H]2[C@@H](COP(S)(=O)O[C@@H]5[C@@H](COP(S)(=O)O[C@H]6[C@H]7OCC[C@]6(COP(S)(=O)O[C@H]6[C@H]8OCC[C@]6(COP(S)(=O)O[C@@H]6[C@@H](COP(S)(=O)O[C@H]9[C@H]%10OCC[C@]9(CO)O[C@H]%10N9C=C(C)C(N)=NC9=O)O[C@H]([C@@H]6OC)N6C=NC9=C6N=C(N)NC9=O)O[C@H]8N6C=C(C)C(N)=NC6=O)O[C@H]7N6C=C(C)C(=O)NC6=O)O[C@H]([C@@H]5OC)N5C=NC6=C5N=C(N)NC6=O)O[C@H]([C@@H]2OC)N2C=CC(N)=NC2=O)O[C@H]4N2C=C(C)C(N)=NC2=O)O[C@H]3N2C=C(C)C(N)=NC2=O)O[C@H]1N1C=NC2=C(N)N=CN=C12

References

General References

Not Available

External Links

Not Available

Clinical Trials

Clinical Trials

Clinical Trial & Rare Diseases Add-on Data Package

Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package

Phase	Status	Purpose	Conditions	Count	Start Date	Why Stopped	100+ additional columns
Unlock 175K+ rows when you subscribe.View sample data
2	Active Not Recruiting	Treatment	Duchenne Muscular Dystrophy (DMD)	1	somestatus	stop reason	just information to hide
1, 2	Completed	Treatment	Duchenne Muscular Dystrophy (DMD)	1	somestatus	stop reason	just information to hide

Unlock 75,000+ rows when you subscribe

Explore data packages curated & structured to speed up your pharmaceutical research

View Sample Data

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Not Available

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

Predicted Properties

Property	Value	Source

Predicted ADMET Features

Not Available

Spectra

Mass Spec (NIST)

Not Available

Spectra

Not Available

Chromatographic Properties

Collision Cross Sections (CCS)

Not Available

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at July 04, 2024 19:57 / Updated at July 08, 2024 11:27